{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:40:39Z","timestamp":1792633239448,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-96769-y","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T20:47:20Z","timestamp":1744490840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Integrated serological surveillance for neglected tropical diseases, vaccine-preventable diseases, and arboviruses in Samoa, 2018"],"prefix":"10.1038","volume":"15","author":[{"given":"Harriet L. S.","family":"Lawford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen J.","family":"Mayfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipina Amosa-Lei","family":"Sam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satupaitea","family":"Viali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tito","family":"Kamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen L.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"key":"96769_CR1","unstructured":"Pan American Health Organization. Toolkit for Integrated Serosurveillance of Communicable Diseases in the Americas (Pan American Health Organization, 2022)."},{"issue":"01","key":"96769_CR2","first-page":"1","volume":"75","author":"O World Health","year":"2000","unstructured":"World Health, O. An integrated approach to communicable disease surveillance. Wkly. Epidemiol. Record Relev\u00e9 \u00c9pid\u00e9miologique Hebdomadaire. 75 (01), 1\u20137 (2000).","journal-title":"Wkly. Epidemiol. Record Relev\u00e9 \u00c9pid\u00e9miologique Hebdomadaire"},{"key":"96769_CR3","unstructured":"Pan American Health, O. & Pan American Health, O. Integrated serological surveillance of communicable diseases using the multiplex bead assay in the region of the Americas: Report of the Fourth Regional Meeting. Meeting reports (PAHO, 2024)."},{"issue":"3","key":"96769_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/infdis\/jiy137","volume":"218","author":"AK Winter","year":"2018","unstructured":"Winter, A. K. et al. Benefits and challenges in using Seroprevalence data to inform models for measles and Rubella elimination. J. Infect. Dis. 218 (3), 355\u2013364 (2018).","journal-title":"J. Infect. Dis."},{"key":"96769_CR5","doi-asserted-by":"publisher","first-page":"897013","DOI":"10.3389\/fpubh.2022.897013","volume":"10","author":"Y Chan","year":"2022","unstructured":"Chan, Y. et al. Multiplex serology for measurement of IgG antibodies against eleven infectious diseases in a National serosurvey: Haiti 2014\u20132015. Front. Public. Health. 10, 897013 (2022).","journal-title":"Front. Public. Health"},{"issue":"1","key":"96769_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1586\/14737159.7.1.87","volume":"7","author":"MM Ling","year":"2007","unstructured":"Ling, M. M., Ricks, C. & Lea, P. Multiplexing molecular diagnostics and immunoassays using emerging microarray technologies. Expert Rev. Mol. Diagn. 7 (1), 87\u201398 (2007).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"96769_CR7","doi-asserted-by":"publisher","first-page":"326918","DOI":"10.1155\/2015\/326918","volume":"2015","author":"S Purohit","year":"2015","unstructured":"Purohit, S., Sharma, A. & She, J. X. Luminex and other multiplex high throughput technologies for the identification of, and host response to, environmental triggers of type 1 diabetes. Biomed. Res. Int. 2015, 326918 (2015).","journal-title":"Biomed. Res. Int."},{"issue":"12","key":"96769_CR8","doi-asserted-by":"publisher","first-page":"e0008927","DOI":"10.1371\/journal.pntd.0008927","volume":"14","author":"CL Lau","year":"2020","unstructured":"Lau, C. L. et al. Lymphatic filariasis epidemiology in Samoa in 2018: geographic clustering and higher antigen prevalence in older age groups. PLoS Negl. Trop. Dis. 14 (12), e0008927 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"96769_CR9","doi-asserted-by":"crossref","unstructured":"Lawford, H. et al. Anti-filarial antibodies are sensitive indicators of lymphatic filariasis transmission and enable identification of high-risk populations and hotspots. Int. J. Infect. Dis., 107194 (2024).","DOI":"10.1016\/j.ijid.2024.107194"},{"key":"96769_CR10","doi-asserted-by":"crossref","unstructured":"Graves, P. M. et al. Triple-drug treatment is effective for lymphatic filariasis microfilaria clearance in Samoa. Trop. Med. Infect. Dis. 6(2) (2021).","DOI":"10.3390\/tropicalmed6020044"},{"issue":"8","key":"96769_CR11","doi-asserted-by":"publisher","first-page":"e0011549","DOI":"10.1371\/journal.pntd.0011549","volume":"17","author":"GA Willis","year":"2023","unstructured":"Willis, G. A. et al. Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018\u20132019. PLoS Negl. Trop. Dis. 17 (8), e0011549 (2023).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"11","key":"96769_CR12","doi-asserted-by":"publisher","first-page":"e1873","DOI":"10.1371\/journal.pntd.0001873","volume":"6","author":"EB Goodhew","year":"2012","unstructured":"Goodhew, E. B. et al. CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl. Trop. Dis. 6 (11), e1873 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"96769_CR13","unstructured":"Samoa Bureau of Statistics. (Census, 2016)."},{"key":"96769_CR14","unstructured":"World Health Organization. Ending the Neglect To Attain the Sustainable Development Goals: a Road Map for Neglected Tropical Diseases 2021\u20132030 (World Health Organization, 2020)."},{"key":"96769_CR15","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.12688\/gatesopenres.13065.1","volume":"3","author":"The roadmap towards elimination of lymphatic filariasis","year":"2019","unstructured":"The roadmap towards elimination of lymphatic filariasis. By 2030: insights from quantitative and mathematical modelling. Gates Open. Res. 3, 1538 (2019).","journal-title":"Gates Open. Res."},{"key":"96769_CR16","unstructured":"World Health Organisation. Trachoma Status of Elimination. https:\/\/apps.who.int\/neglected_diseases\/ntddata\/trachoma\/trachoma.html ( 2024)."},{"issue":"11","key":"96769_CR17","doi-asserted-by":"publisher","first-page":"e0207393","DOI":"10.1371\/journal.pone.0207393","volume":"13","author":"BL Handley","year":"2018","unstructured":"Handley, B. L., Roberts, C. H. & Butcher, R. A systematic review of historical and contemporary evidence of trachoma endemicity in the Pacific Islands. PLoS One. 13 (11), e0207393 (2018).","journal-title":"PLoS One"},{"issue":"7","key":"96769_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1442-9071.2007.01556.x","volume":"35","author":"J Ramke","year":"2007","unstructured":"Ramke, J., Brian, G. & Du Toit, R. Eye disease and care at hospital clinics in cook Islands, Fiji, Samoa and Tonga. Clin. Exp. Ophthalmol. 35 (7), 627\u2013634 (2007).","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"1420","key":"96769_CR19","first-page":"25","volume":"128","author":"J Lees","year":"2015","unstructured":"Lees, J., McCool, J. & Woodward, A. Eye health outreach services in the Pacific Islands region: an updated profile. New. Z. Med. J. (Online). 128 (1420), 25 (2015).","journal-title":"New. Z. Med. J. (Online)"},{"issue":"1","key":"96769_CR20","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1038\/s41467-023-38940-5","volume":"14","author":"C Tedijanto","year":"2023","unstructured":"Tedijanto, C. et al. Monitoring transmission intensity of trachoma with serology. Nat. Commun. 14 (1), 3269 (2023).","journal-title":"Nat. Commun."},{"key":"96769_CR21","unstructured":"World Health Organization. Yaws (Endemic treponematoses) 2024 [Available from: https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/yaws-endemic-treponematoses"},{"issue":"9954","key":"96769_CR22","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/S0140-6736(14)61977-2","volume":"384","author":"V-M Cao-Lormeau","year":"2014","unstructured":"Cao-Lormeau, V-M. & Musso, D. Emerging arboviruses in the Pacific. Lancet 384 (9954), 1571\u20131572 (2014).","journal-title":"Lancet"},{"key":"96769_CR23","doi-asserted-by":"crossref","unstructured":"Matthews, R. J. et al. Arboviral disease outbreaks in the Pacific Islands countries and areas, 2014 to 2020: A systematic literature and document review. Pathogens 11(1). (2022).","DOI":"10.3390\/pathogens11010074"},{"issue":"1","key":"96769_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/infdis\/jiad529","volume":"229","author":"AS Mahmud","year":"2023","unstructured":"Mahmud, A. S., Bhattacharjee, J., Baker, R. E. & Martinez, P. P. Alarming trends in dengue incidence and mortality in Bangladesh. J. Infect. Dis. 229 (1), 4\u20136 (2023).","journal-title":"J. Infect. Dis."},{"issue":"2","key":"96769_CR25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3201\/eid1902.120464","volume":"19","author":"J Duncombe","year":"2013","unstructured":"Duncombe, J. et al. Seroprevalence of dengue in American Samoa, 2010. Emerg. Infect. Dis. 19 (2), 324\u2013326 (2013).","journal-title":"Emerg. Infect. Dis."},{"key":"96769_CR26","doi-asserted-by":"crossref","unstructured":"Desai, A. N. & Majumder, M. S. What Is Herd Immunity? JAMA 324(20), 2113 (2020).","DOI":"10.1001\/jama.2020.20895"},{"key":"96769_CR27","unstructured":"World Health Organization Regional Office for the Western Pacific. 32nd Meeting of the Technical Advisory Group on Immunization and Vaccine-Preventable Diseases in the Western Pacific Region (2023)."},{"key":"96769_CR28","unstructured":"World Health Organisation. Measles and rubella. https:\/\/www.who.int\/westernpacific\/health-topics\/measles#tab=tab_1 (2024)."},{"issue":"3","key":"96769_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S1473-3099(20)30053-0","volume":"20","author":"AT Craig","year":"2020","unstructured":"Craig, A. T., Heywood, A. E. & Worth, H. Measles epidemic in Samoa and other Pacific Islands. Lancet Infect. Dis. 20 (3), 273\u2013275 (2020).","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"96769_CR30","doi-asserted-by":"publisher","first-page":"e13294","DOI":"10.1111\/aji.13294","volume":"84","author":"WJ Kung","year":"2020","unstructured":"Kung, W. J. et al. Faster waning of the rubella-specific immune response in young pregnant women immunized with MMR at 15 months. Am. J. Reprod. Immunol. 84 (4), e13294 (2020).","journal-title":"Am. J. Reprod. Immunol."},{"key":"96769_CR31","unstructured":"UNICEF. Vaccination and Immunization Statistics - UNICEF Data. https:\/\/data.unicef.org\/topic\/child-health\/immunization\/ (2024)."},{"key":"96769_CR32","unstructured":"Malaria Consortium. Vector control: the untapped potential for neglected tropical diseases (2017)."},{"issue":"Supplement_2","key":"96769_CR33","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1093\/cid\/ciae021","volume":"78","author":"K Kura","year":"2024","unstructured":"Kura, K. et al. How does the proportion of never treatment influence the success of mass drug administration programs for the elimination of lymphatic filariasis? Clin. Infect. Dis. 78 (Supplement_2), S93\u2013s100 (2024).","journal-title":"Clin. Infect. Dis."},{"key":"96769_CR34","doi-asserted-by":"crossref","unstructured":"Brady, M. A. et al. Persons \u2018never treated\u2019 in mass drug administration for lymphatic filariasis: identifying programmatic and research needs from a series of research review meetings 2020\u20132021. Int. Health (2023).","DOI":"10.1093\/inthealth\/ihad091"},{"issue":"11","key":"96769_CR35","doi-asserted-by":"publisher","first-page":"e0008854","DOI":"10.1371\/journal.pntd.0008854","volume":"14","author":"GA Willis","year":"2020","unstructured":"Willis, G. A. et al. A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018. PLoS Negl. Trop. Dis. 14 (11), e0008854 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"96769_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13073-018-0568-8","volume":"10","author":"P Scepanovic","year":"2018","unstructured":"Scepanovic, P. et al. Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines. Genome Med. 10 (1), 59 (2018).","journal-title":"Genome Med."},{"key":"96769_CR37","doi-asserted-by":"crossref","unstructured":"Zaidi, M. B. et al. y, Serological tests reveal significant cross-reactive human antibody responses to Zika and Dengue viruses in the Mexican population. Acta Trop. 201, 105201 (2020).","DOI":"10.1016\/j.actatropica.2019.105201"},{"issue":"7","key":"96769_CR38","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/v16071098","volume":"16","author":"A Posadas-Mondrag\u00f3n","year":"2024","unstructured":"Posadas-Mondrag\u00f3n, A. et al. Cross-neutralizing anti-chikungunya and anti-dengue 2 IgG antibodies from patients and BALB\/c mice against dengue and Chikungunya viruses. Viruses 16 (7), 1098 (2024).","journal-title":"Viruses"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96769-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96769-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96769-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T20:47:30Z","timestamp":1744490850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96769-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96769"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96769-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics approvals were granted by the Samoan Ministry of Health and The Australian National University Human Research Ethics Committee (protocol 2018\/341) and ratified by The University of Queensland Human Research Ethics Committee (2021\/HE000895). The study was conducted in close collaboration with the Samoa Ministry of Health, the WHO country office in Samoa, and the Samoa Red Cross. Written informed consent was obtained from adult participants. For participants aged\u2009<\u200918 years, verbal assent was obtained from the child and formal written consent was obtained from a parent or guardian. All research activities were performed in accordance with the relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"12667"}}